Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?
Remyelination by Resident Oligodendrocyte Precursor Cells in a Xenopus laevis Inducible Model of Demyelination.
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Use and medicalization of marihuana in cancer patients.
Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.
The meninges: new therapeutic targets for multiple sclerosis.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
[Neuromyelitis optica in children. Two case reports.]
Cognitive impairment in Chinese neuromyelitis optica.
Low serum urate levels are associated to female gender in multiple sclerosis patients.
Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Natalizumab in the pediatric MS population: results of the Italian registry.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
Pages
« first
‹ previous
…
249
250
251
252
253
254
255
256
257
…
next ›
last »